Related Experiment Videos
Immunomodulation of cancer: potential use of selectively replicating agents
1University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15261, USA.
The Journal of Clinical Investigation
|May 3, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer.
Cell death & disease·2014
Enhancing Gemcitabine Uptake by Promoting Dimerization of the ENT1 Transporter Improves Sarcoma Patient Response Rate.
The Journal of clinical investigation·2026
CD8⁺ Regulatory T Cells Shorten Neutrophil Lifespan to Reduce Hemorrhagic Transformation After Ischemic Stroke.
The Journal of clinical investigation·2026
Multiple sclerosis-associated CD226 variant disrupts vitamin D-induced type I Treg differentiation by impairing LFA-1 activation.
The Journal of clinical investigation·2026
Conserved neuronal-like and secretory programs define the spatial architecture of gastroenteropancreatic neuroendocrine tumors.
The Journal of clinical investigation·2026
Enhancing Treg persistence by inhibiting necroptosis restrains autoimmune pathology.
The Journal of clinical investigation·2026
XY0206 targets FLT3-dependent resistance states in acute myeloid leukemia.
The Journal of clinical investigation·2026